Cancer “Liquid Biopsy” Blood Test Gets Expanded FDA Approval

SEMrush
FDA has expanded the approved uses of the FoundationOne Liquid CDx blood test, known as a liquid biopsy, that can help doctors pick specific treatments for some people with cancer. When used in this way, the test is known as a companion diagnostic.
[automaticbacklinks]